Migraine Linked to Hyperacusis and Tinnitus

A systemic disorder of multisensory sensitization, migraine is now understood to extend far beyond head pain. New research proposes that common auditory symptoms, including hearing loss, tinnitus, and hyperacusis, are not merely coincidental companions to migraine but integral manifestations of its underlying biology. A 2026 review in the *Journal of Neurology* synthesizes data revealing that 15% to 49% of migraine patients report comorbid auditory symptoms, with nearly two-thirds showing objective electrophysiological abnormalities [Xu et al., 2026, PMID: 42371148]. The authors argue that optimal clinical management is hindered by a fragmented understanding of these links, variable clinical assessments, and scattered treatment evidence.

### The Three-Axis Model of Migraine-Related Auditory Dysfunction

The team led by Xu, Zhai, and Chen moves past the idea of simple comorbidity, proposing a unified “peripheral-to-central continuum.” They identify three primary, interacting pathological axes. The first involves **anatomical and hydrodynamic vulnerabilities**. Abnormalities in blood flow and fluid exchange between the brain and inner ear can create localized microvascular ischemia, potentially damaging delicate cochlear structures. This may explain the observed link between migraine and sensorineural hearing loss, a connection also explored in our previous article on Migraines and Hearing Disorders: Key Connections.

The second axis centers on **localized neurochemical imbalances** in the auditory pathway. The review details mechanisms like glutamate excitotoxicity, dysregulated neuropeptide signaling (e.g., CGRP, a key migraine mediator), and innate immune activation. These processes can directly disrupt inner ear homeostasis, generating peripheral signals that feed into the central nervous system. Such inflammatory and excitatory mechanisms share conceptual ground with other conditions, like the neuroinflammatory Autoimmune Inner Ear and Balance Disorders.

The third, and perhaps most critical for conditions like tinnitus and hyperacusis, is **central sensitization**. The migraine brain exhibits heightened neural plasticity and impaired efferent (top-down) gating of auditory signals. This leads to a state where normal or sub-threshold auditory input is pathologically amplified. The authors describe a model of thalamocortical dysrhythmia, where abnormal oscillatory brain rhythms facilitate the perception of phantom sounds (tinnitus) and reduced sound tolerance.

### From Mechanism to Management: A New Therapeutic Framework

A primary contribution of this review is its re-categorization of treatment strategies according to the specific pathological axis they address. This creates a more rational approach than trying generic “tinnitus” or “migraine” treatments without physiological rationale.

**Blocking Upstream Migraine Pathways:** This first-line approach uses established migraine preventives (e.g., CGRP monoclonal antibodies, beta-blockers, topiramate) to reduce the systemic “sensitization engine.” By dampening the overall migraine burden, the downstream auditory symptoms may also improve.

**Protecting the Cochlear Microenvironment:** Emerging strategies here aim to interrupt the local damage in the inner ear. This could include antioxidants to combat oxidative stress, glutamate modulators to prevent excitotoxicity, or agents designed to stabilize inner ear fluid dynamics.

**Correcting Central Hypersensitivity:** Treatments here target the brain’s maladaptive plasticity. This is where sound therapy, cognitive behavioral therapy (CBT), and neuromodulation techniques (like transcranial magnetic stimulation) have a role. These approaches aim to retrain auditory processing networks. The principle of using CBT to alter maladaptive neural pathways is similarly effective in other domains, such as the long-term outcomes of cognitive behavioral therapy for insomnia, as discussed in a cross-site analysis on SleepScience.space.

### Practical Implications for Patients and Clinicians

The high prevalence figures—up to half of migraine patients experiencing auditory issues—demand a shift in clinical practice. For patients with migraine, particularly those with aura, new or worsening hearing symptoms like tinnitus, sound sensitivity, or subjective hearing changes should be actively discussed with a healthcare provider. For audiologists and otolaryngologists evaluating patients with these auditory complaints, taking a detailed migraine history becomes essential.

The authors advocate for more standardized, comprehensive audiological assessments in migraine studies to better phenotype patients. Understanding whether a patient’s hyperacusis stems primarily from peripheral cochlear vulnerability versus central gain could one day guide targeted treatment selection. This move toward precise phenotyping aligns with broader trends in hearing health, as seen in research into the Four Psychosocial Profiles of Tinnitus Patients.

Ultimately, the review by Xu and colleagues establishes a strong biological rationale for the migraine-auditory symptom link, moving it from anecdotal observation to a structured model of disease. This framework not only clarifies why these conditions co-occur but also provides a clear roadmap for future research and more integrated, cross-disciplinary patient care.